CTI BioPharma Corp.

NASDAQ: CTIC · Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM

CTI BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.42M 65.45M
Short-Term Investments
49.52M n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
1.23M 770K
Receivables
15.39M n/a
Inventory
733K n/a
Other Current Assets
3.34M 2.93M
Total Current Assets
99.4M 68.38M
Property-Plant & Equipment
2.08M 3.29M
Goodwill & Intangibles
23.23M n/a
Total Long-Term Assets
26.53M 4.05M
Total Assets
125.92M 72.43M
Account Payables
2.01M 3.89M
Deferred Revenue
n/a 13.72M
Short-Term Debt
47.94M 48.54M
Other Current Liabilities
31.18M 14.22M
Total Current Liabilities
81.13M 66.65M
Long-Term Debt
n/a 2.02M
Other Long-Term Liabilities
62.37M n/a
Total Long-Term Liabilities
62.37M 2.02M
Total Liabilities
143.5M 68.67M
Total Debt
49.96M 50.56M
Common Stock
131K 100K
Retained Earnings
-2.52B -2.43B
Comprehensive Income
-35K n/a
Shareholders Equity
-17.58M 3.77M
Total Investments
49.52M n/a